EGFR Cooperates with EGFRvIII to Recruit Macrophages in Glioblastoma.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 30401716.
- Also identified by DOI 10.1158/0008-5472.CAN-17-3551 and PMC identifier 6295222.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
: Amplification of the <i>EGFR</i> gene and its truncation mutant <i>EGFRvIII</i> are hallmarks of glioblastoma. Although coexpression of EGFR and EGFRvIII confers a growth advantage, how EGFR and EGFRvIII influence the tumor microenvironment remains incompletely understood. Here, we show that EGFR and EGFRvIII cooperate to induce macrophage infiltration via upregulation of the chemokine CCL2. EGFRvIII was significantly enriched in glioblastoma patient samples with high CCL2, and knockout of CCL2 in tumors coexpressing EGFR and EGFRvIII led to decreased infiltration of macrophages. KRAS was a critical signaling intermediate for EGFR- and EGFRvIII-induced expression of CCL2. Our results illustrate how EGFR and EGFRvIII direct the microenvironment in glioblastoma. SIGNIFICANCE: Full-length EGFR and truncated EGFRvIII work through KRAS to upregulate the chemokine CCL2 and drive macrophage infiltration in glioblastoma.
Medical subject headings
- Brain Neoplasms
- Chemokine CCL2
- ErbB Receptors
- Glioblastoma
- Macrophages
- Proto-Oncogene Proteins p21(ras)